Search Advanced Search

Archived news

2005

Search for

Rotigotine in Advanced Parkinson's Disease Shows Positive Trial ResultsPhase III trial results shows statistically significant and clinically relevant reduction in 'off' time. The results support the favorable data of previous trials with rotigotine. 02 December 2005
Neupro® Receives Positive Opinion from European CHMP for the Treatment of Early Parkinson's DiseaseClinical trials have shown efficacy and safety in early Parkinson's disease patients and a potential for long term benefit. First market launches of the Parkinson's patch within Europe will be in the first half of 2006. 01 December 2005
Initiation of largest disease modification trial to study effect of Azilect® in slowing progression of Parkinson's DiseaseThe largest clinical study to investigate disease modification in Parkinson's disease (PD) has now enrolled its first patients in Europe and North America. 30 November 2005
Solvay Pharmaceuticals has obtained market authorization for DUODOPA®, the product for treating advanced Parkinson's disease in DUODOPA® now has a registration in Sweden, Austria, Germany, Denmark, Spain, Finland, France, The Netherlands, Norway, Portugal, Belgium, Greece, Ireland, Italy, United Kingdom, Cyprus, Czech Republic, Estonia, Hungary, Iceland, Liechtenstein, Lithuania, Luxembourg, Latvia, Malta, Poland, Slovenia, and Slovakia; 29 November 2005
DVD of the DBS for Dystonia Conference at Belvoir Castle, Leicestershire - UK's First Deep Brain Stimulation for Dystonia ConferOn Saturday 3rd September 2005, the UK's first conference for people with Dystonia and who have had or are considering a surgical procedure known as Deep Brain Stimulation (DBS), took place at the magnificent Belvoir Castle bringing together leading experts and patients from Belgium, Netherlands, America and across the UK. 16 November 2005
Normal movement restored and new neurons formed in model of Parkinson's diseaseStockholm, Sweden, Nov. 15, 2005 – Two weeks of local administration of sNN0031, a compound under development for Parkinson's disease, normalized movement and restored dopamine balance in a rat model of the disease. 15 November 2005
6th EuroYapmeet Conference: paints brighter future for patients with PDCarrying as its theme, “Embrace tomorrow. Make the future brightening not frightening,” the 6th European Conference for Younger People with Parkinson's disease (Dublin, 7-9 October) featured a series of upbeat presentations on improving management and developing new therapies. 25 October 2005
The Parkinson's Disease Society (PDS) is pleased to announce the appointment of Steve Ford as its new Chief ExecutiveSteve, who takes over from Linda Kelly, was previously Chief Executive of South West Kent Primary Care Trust. He has over twenty years experience of working in the health service but this is his first step into the charity sector. 13 October 2005
EPDA President, Mary Baker MBE, receives Patient Advocacy Award presented by Spanish Patients Association04 October 2005
Treble Reel for Parkinson's Disease ResearchOn October 8, 2005 the Broesler School of Irish Dance held a Treble Reel for Charity in Carmel, NY at their annual feisanna. 04 October 2005

Page: [1] [2] [3] [4]

[ Next » ]